Events

Past events

  • ILF/CIPHER Webinar: Report back from PADO 3
    28 February 2017

    The ILF and CIPHER, in collaboration with WHO, held a webinar to disseminate the main outcomes from the Paediatric ARV Drug Optimization (PADO) 3 meeting - which took place during the Geneva Paediatrics Week.

    Read more

  • ILF/CIPHER Webinar: Report back from the paediatrics week
    15 December 2016

    The ILF and CIPHER held a webinar to disseminate, beyond stakeholders directly involved, the main outcomes of the Geneva paediatrics HIV week “Making the right drugs available for children with HIV”.

    Read more

  • CTA Meeting on Paediatric ARVs: Introducing the Global Accelerator for Paediatric Formulations
    5 December 2016 | Geneva, Switzerland (By invitation only)

    On 5 December 2016, the Global Pediatric Antiretroviral Commitment-to-Action (CTA) partner organizations convened key stakeholders in the paediatric ARV space to accelerate joint efforts to identify innovative approaches to fast-track development and introduce priority paediatric formulations.

    Read more

  • ILF Thematic Roundtable on HIV Diagnostics: Addressing challenges of early infant diagnosis and point of care diagnostic
    19 July 2016 | Durban, South Africa (By invitation only)

    In line with UNAIDS 90-90-90 targets, by 2020, 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy, and 90% of all people receiving antiretroviral therapy will achieve viral suppression.

    Read more

  • CTA/ILF/CIPHER Thematic Roundtable on Paediatric ARVs: Fast tracking development of priority ARV formulations
    16 July 2016 | Durban, South Africa (By invitation only)

    The global community has identified priorities for future development of paediatric ARV formulations through the Paediatric ARV Drug Optimization (PADO) consultations; however, there are many challenges to making these formulations available. Existing regulatory frameworks promote development of paediatric formulations, but implementation of those frameworks has been slow and sometimes inefficient.

    Read more

  • ILF/CIPHER Thematic Roundtable on Paediatric ARVs: Stimulating development of the most needed formulations
    7 March 2016 | Geneva, Switzerland (By invitation only)

    The global community has identified priorities for future R&D for paediatric ARV formulations through the Paediatric ARV Drug Optimization (PADO) meetings; however, there are many challenges in making these formulations available.

    Read more

  • Webinar: Discussion on opportunities for industry through EDCTP
    22 October 2015

    The European & Developing Countries Clinical Trials Partnership (EDCTP, www.edctp.org) is a public-public partnership of 14 European and 14 sub-Saharan African countries supported by the European Union.

    Read more

  • ILF/CIPHER PADO/IATT Update for ARV Manufacturers
    19 October 2015 (By invitation only)

    As part of the thematic roundtable series on paediatric ARVs, the ILF and CIPHER invited both generic and originator ARV manufacturers for a webinar focusing on some of the recent progress in the paediatric ARV space.

    Read more

  • IAS-Industry Consultation on the Integration of HIV and Other Diseases: From Single Disease to Complete Patient Management (IAS 2015)
    21 July 2015 | Vancouver, Canada (By invitation only)

    This IAS-Industry Consultation on the Integration of HIV and Other Diseases: From Single Disease to Complete Patient Management provided a platform for participants to meet and discuss the challenges and opportunities to “bridge the gap” of integrated approaches, and health system strengthening between HIV and TB/HCV/NCDs.

    Read more

  • ILF/Co-Infections Thematic Roundtable on the Road to HCV Eradication (IAS 2015)
    20 July 2015 | Vancouver, Canada (By invitation only)

    This ILF/Co-Infections Thematic Roundtable took a step further from the 2nd International HIV/Viral Hepatitis Co-Infection Meeting (www.coinfectionmeeting.com) and focused on the development of a general, visionary and long-term agenda for HCV eradication. 

    Read more

  • ILF/CIPHER Thematic Roundtable on Paediatric HIV Diagnostics: Early Infant Diagnosis and Beyond (IAS 2015)
    19 July 2015 | Vancouver, Canada (By invitation only)

    This meeting started by looking at the paediatric diagnostics continuum, from development to implementation, highlighting challenges along the way and existing initiatives. An overview of WHO guidance as well as insights working-up to the next revision of the 2013 Consolidated Guidelines was also provided.

    Read more

  • ILF/CIPHER Thematic Roundtable on Paediatric ARVs Aligning, coordinating and accelerating actions to provide better ARVs for children
    18 March 2015 | Geneva, Switzerland

    Following the success of the roundtables on paediatric HIV that the IAS Industry Liaison Forum (ILF) and the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) held in Geneva, Switzerland, a follow-up roundtable on paediatric ARVs was organized.

    Read more

  • IAS-ILF Thematic Roundtable on Key Populations
    24 February 2015 | Seattle, WA, USA

    To complement the work of the IAS’s KPs Priority, the IAS-ILF held a thematic roundtable on Key Populations (KPs).

    Read more

  • IAS-Industry Consultation
    22 July 2014 | Melbourne, Australia

    Following the success of the first IAS-Industry Consultation held in Boston, USA, in March 2014, the second IAS-Industry Consultation took place in conjunction with AIDS 2014.

    Meeting agenda | List of participants | Overview presentation

  • IAS-ILF/CIPHER Thematic Roundtable on Paediatric HIV (AIDS 2014)
    19 July 2014 | Melbourne, Australia

    Following the success of the IAS-ILF Industry Roundtable on Paediatric Antiretrovirals (ARVs), held in Geneva, Switzerland, in November 2013, a follow-up roundtable on paediatric HIV was held to widen the scope of the discussion from including mainly ARV manufacturers and international organizations to include investigators from the largest HIV paediatric cohorts worldwide (through the CIPHER cohort collaboration project).

    Read more

  • IAS-ILF activity at INTEREST 2014
    5 May 2014 | Lusaka, Zambia

    Symposium at the 8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-poor Settings (INTEREST 2014).

    Read more

  • IAS-Industry Consultation
    4 March 2014 | Boston, USA

    This closed meeting was an occasion for the IAS to present its strategic priorities while getting insights from industry partners regarding their interests to foster further collaboration.

    Read more

  • Paediatric antiretrovirals: The barriers to and solutions for improved access to optimal drugs in resource-limited settings
    27 November 2013 | Geneva, Switzerland

    Industry roundtable on paediatric ARVs

    Read more

  • IAS-ILF - UNICEF satellite: Beyond Option B+
    1 July 2013 | Kuala Lumpur, Malaysia

    Satellite session at IAS 2013

    Read more

  • IAS-ILF -AVAC satellite: Expanding HIV Prevention Options for Women
    30 June 2013 | Kuala Lumpur, Malaysia

    Satellite session at IAS 2013

    Read more

  • Sex and gender differences in ARV-based prevention research
    3 March 2013 | Atlanta, Georgia, USA

    Affiliated event at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013)

    Read more

  • Catching children before they fall: what it will take to address the urgent drug development needs of young children with living with HIV
    22 July 2012 | Washington D.C., USA

    Public satellite meeting in conjuction with the XIX International AIDS Conference in Washington D.C.

    Read more

  • Prevention of vertical transmission and beyond: How to identify, enroll and retain children in treatment programmes in resource limited settings?
    22 July 2012 | Washington D.C., USA

    Public satellite meeting in conjuction with the XIX International AIDS Conference in Washington D.C.

    Read more

  • Gender and science: Shifting the paradigm in HIV research
    23 July 2012 | Washington D.C., USA

    Public satellite meeting in conjuction with the XIX International AIDS Conference in Washington D.C.

    Read more

  • Pharmacology of ARVs: How HIV-1 infection differs in children and women
    5 March 2012 | Seattle, USA

    Affiliated event at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)

    Read more

  • Operational & implementation challenges in scaling up PMTCT programmes in resource limited settings
    17 July 2011 | Rome, Italy

    Public satellite meeting in conjuction with the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy. Co-hosted with UNICEF

    Agenda | Meeting report

  • Challenges in the development and procurement of paediatric antiretroviral formulations
    17 July 2011 | Rome, Italy

    Public satellite meeting in conjuction with the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy. Co-hosted with UNICEF & Clinton HIV/AIDS Initiative (CHAI).

    Agenda | Meeting report

  • What does the future of ARV-based prevention look like?
    18 July 2011 | Rome, Italy

    Public satellite meeting in conjuction with the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy. Co-hosted with AVAC.

    Agenda | Meeting report

  • Paediatric drug resistance in resource limited settings: jeopardising future treatment options
    27 February 2011 | Boston, USA (CROI 2011)

    Public satellite meeting in conjuction with the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome, Italy. Co-hosted with AVAC.

    Read more

  • Scaling up early infant diagnosis of HIV as the bridge between prevention, care and treatment: successes, challenges and potential solutions
    18 July 2010 | Vienna, Austria

    Session at the XVIII International AIDS Conference (AIDS 2010)

    Read more

  • The promise and perils of ARV-based prevention: making it a reality on the ground
    18 July 2010 | Vienna, Austria

    Session at the XVIII International AIDS Conference (AIDS 2010)

    Read more

  • Using antiretrovirals to prevent HIV: implications of the outcome of the CAPRISA 004 tenofovir-gel microbicide trial
    20 July 2010 | Vienna, Austria

    Session at the XVIII International AIDS Conference (AIDS 2010)

    Agenda

  • Pediatric public-private partnership
    21 July 2010 | Vienna, Austria (by invitation only)

    Session at the XVIII International AIDS Conference (AIDS 2010)

  • Building consensus on clinical and operations research priorities for women and children
    19 July 2009 | Cape Town, South Africa

    Session at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009)

    Agenda | IAS-ILF Mapping Exercise - Final Report | IAS-ILF Mapping Exercise Summary Report | Draft Environmental Scan

  • The promise and perils of ARV-based prevention: a dialogue of informed optimism & skepticism
    19 July 2009 | Cape Town, South Africa

    IAS-ILF /AVAC Satellite meeting at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009)

    Agenda | Meeting report | aidsmap news article

  • Mapping gaps in clinical research in resource-limited settings: focus on paediatric treatment
    8 February 2009 | Montreal, Canada,

    Meeting at the 16th Conference on Retroviruses and Opportunistic Infections (CROI)

    Read more

  • Industry and HIV clinical research – what is being learned in Africa? Focusing on women and children
    3 December 2008 | Dakar, Senegal

    Meeting at the 15th International Conference on AIDS and STIs in Africa

    Read more

  • The role of industry in development of ARV-based prevention technologies for women
    4 August 2008 | Mexico City, Mexico

    Session at the XVII International AIDS Conference (AIDS 2008)

    Read more

  • Helping define a research agenda for women
    5 May 2008 | Moscow, Russian Federation

    Meeting at the Second Eastern Europe and Central Asia AIDS Conference (EECAAC)

    Agenda | Meeting report

  • Defining a research agenda for women in resource-poor countries
    3 February 2008 | Boston, USA

    Meeting at the 15th Conference on Retrovirus and Opportunistic Infections (CROI)

    Agenda | Meeting report

  • Defining industry responsibilities in Pre-exposure Prophylaxis (PReP) research and implementation
    25 February 2007 | Los Angeles, USA

    Meeting at the 14th Conference on Retrovirus and Opportunistic Infections (CROI)

    Agenda | Meeting report

  • Are we prepared for PrEP? The challenges of implementing proven biomedical prevention technologies
    22 July 2007 | Sydney, Australia

    Meeting at the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2007)

    Agenda

  • PrEP implementation policy forum: developing country-level preparation and capacity for PrEP implementation
    22 July 2007 | Sydney, Australia

    Meeting at the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2007)

    Agenda | Meeting report

  • Scientific and investment considerations for research on Pre-exposure Prophylaxis (PrEP)
    5 February 2006 | Denver, USA

    Meeting at the 13th Conference on Retrovirus and Opportunistic Infections (CROI)

    Agenda | Meeting report

  • What if Pre-exposure Prophylaxis (PrEP) works? The challenges of implementing new prevention technologies
    13 August 2006 | Toronto, Canada

    Session at the XVI International AIDS Conference (AIDS 2006)

    Agenda

  • IAS Industry Liaison Forum
    22 February 2005 | Boston, USA

    Meeting at the 12th Conference on Retrovirus and Opportunistic Infections (CROI)

    Meeting report